Coolest Science Story: Treatment for Severe COVID

What's the coolest Ohio State science story of 2022?
We chose three of our favorites. But you get to decide on the winner.

You VOTE for the winner.

Vote here at: https://news.osu.edu/its-time-to-vote-for-ohio-states-coolest-science-story-of-2022/

Blocking an immune response-related molecule holds promise in preventing or treating severe COVID-19 symptoms, Ohio State University research in mice suggests. Scientists traced development of extensive lung damage in infected mice to heightened levels of the molecule triggered by the invading SARS-CoV-2 virus. Blocking the molecule in infected mice reduced inflammation, tissue injury and blood clots in the lungs.

Versions of this molecule, which is an enzyme, exist and have similar functions in both mice and humans – they’re called caspase 11 and caspase 4, respectively. After finding that the enzyme is an attractive therapeutic target, the researchers are exploring compounds that could safely and effectively block its activation.

See complete story at: https://news.osu.edu/blocking-enzyme-could-hold-the-key-to-preventing-treating-severe-covid-19/

Access:
We are working on captioning our videos as soon as possible. If you notice this video has not been captioned three business days after it has been posted, please email us at admin-svc-access@osu.edu.

Видео Coolest Science Story: Treatment for Severe COVID канала Ohio State News